TYSONS, Va. and CARRICK ON SHANNON, Ireland, Sept. 28, 2017 -- Cora Systems, a leading global provider of enterprise portfolio, program and project management (EPPM) solutions, has been named a finalist in the 2017 Pharma Industry Awards. Cora has been honored with the finalist designation in the “Pharma Supplier of the Year” category. The category winner will be announced at a ceremony on October 5 at the Clayton Hotel, Burlington Road, Dublin.
The annual awards program is presented in association with Kuehne + Nagel’s Pharma and Healthcare Division.
“We are extremely honored to have been singled out as a finalist in this prestigious awards program,” said Philip Martin, Founder and Chief Executive Officer of Cora Systems. “Our professional services teams and our EPPM software solution, ProjectVision, have been instrumental in helping pharmaceutical companies of all sizes drive successful outcomes for their projects.”
ProjectVision, Cora’s customized EPPM solution, is an intuitive web-based tool that offers specific benefits to the pharmaceutical industry such as process compliance, risk management, and project cost savings through Lean Management programs. In addition to the software, Cora’s professional services teams provide mentoring to achieve solution ROI in six months, or less. Additionally, Cora’s flexible approach provides a customizable solution that fits seamlessly into existing methodologies and practices, eliminating costly and time consuming re-training.
About Cora Systems
Cora Systems provides EPPM solutions and services to government agencies and large-scale global organizations, including life sciences, healthcare, and engineering & construction. Every day, thousands of project managers across the world use the Cora platform to manage their portfolio of projects, totaling over $ 10 billion in value, across multiple locations, dozens of countries and thousands of users. Headquartered in Ireland and with regional offices in Washington, DC and London (UK), Cora’s client roster includes Allergan, Boston Scientific and Eli Lilly. For more information, visit: www.corasystems.com.
Media Contacts:
Richard Fitzpatrick, Marketing Manager
Cora Systems:
+353 71 962 2078;
[email protected]
Dawn Fontaine
Ripple Effect Communications
508-353-3777
[email protected]


Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 



